Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein ...

Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice ...

Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to ...

Unified Patent Court announces new case management system this summer | Release will be in two phases, with first phase ...

Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, ...

US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and ...

The LSPN Europe 2025 Survey, which comes ahead of LSPN Europe in London in November, invites patent practitioners ...

The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation ...

Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio.

The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular ...

A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a ...

15 April 2025 Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega ...